Jeffrey J Hsu1,2, Yin Tintut1,3,4,2, Linda L Demer1,3,5,2. 1. Department of Medicine. 2. Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California, USA. 3. Department of Physiology. 4. Department of Orthopaedic Surgery. 5. Department of Bioengineering, University of California.
Abstract
PURPOSE OF REVIEW: Lipids and lipoproteins have long been known to contribute to atherosclerosis and cardiovascular calcification. One theme of recent work is the study of lipoprotein (a) [Lp(a)], a lipoprotein particle similar to LDL-cholesterol that carries a long apoprotein tail and most of the circulating oxidized phospholipids. RECENT FINDINGS: In-vitro studies show that Lp(a) stimulates osteoblastic differentiation and mineralization of vascular smooth muscle cells, while the association of Lp(a) with coronary artery calcification continues to have varying results, possibly because of the widely varying threshold levels of Lp(a) chosen for association analyses. Another emerging area in the field of cardiovascular calcification is pathological endothelial-to-mesenchymal transition (EndMT), the process whereby endothelial cell transition into multipotent mesenchymal cells, some of which differentiate into osteochondrogenic cells and mineralize. The effects of lipids and lipoproteins on EndMT suggest that they modulate cardiovascular calcification through multiple mechanisms. There are also emerging trends in imaging of calcific vasculopathy, including: intravascular optical coherence tomography for quantifying plaque characteristics, PET with a radiolabeled NaF tracer, with either CT or MRI to detect coronary plaque vulnerability. SUMMARY: Recent work in this field includes studies of Lp(a), EndMT, and new imaging techniques.
PURPOSE OF REVIEW: Lipids and lipoproteins have long been known to contribute to atherosclerosis and cardiovascular calcification. One theme of recent work is the study of lipoprotein (a) [Lp(a)], a lipoprotein particle similar to LDL-cholesterol that carries a long apoprotein tail and most of the circulating oxidized phospholipids. RECENT FINDINGS: In-vitro studies show that Lp(a) stimulates osteoblastic differentiation and mineralization of vascular smooth muscle cells, while the association of Lp(a) with coronary artery calcification continues to have varying results, possibly because of the widely varying threshold levels of Lp(a) chosen for association analyses. Another emerging area in the field of cardiovascular calcification is pathological endothelial-to-mesenchymal transition (EndMT), the process whereby endothelial cell transition into multipotent mesenchymal cells, some of which differentiate into osteochondrogenic cells and mineralize. The effects of lipids and lipoproteins on EndMT suggest that they modulate cardiovascular calcification through multiple mechanisms. There are also emerging trends in imaging of calcific vasculopathy, including: intravascular optical coherence tomography for quantifying plaque characteristics, PET with a radiolabeled NaF tracer, with either CT or MRI to detect coronary plaque vulnerability. SUMMARY: Recent work in this field includes studies of Lp(a), EndMT, and new imaging techniques.
Authors: Parastou Eslami; Chintan Parmar; Borek Foldyna; Jan-Erik Scholtz; Alexander Ivanov; Roman Zeleznik; Michael T Lu; Maros Ferencik; Ramachandran S Vasan; Kristin Baltrusaitis; Joseph M Massaro; Ralph B D'Agostino; Thomas Mayrhofer; Christopher J O'Donnell; Hugo J W L Aerts; Udo Hoffmann Journal: Radiol Cardiothorac Imaging Date: 2020-02-27
Authors: Dianne H K van Dam-Nolen; Nina C M van Egmond; Kristine Dilba; Kelly Nies; Anja G van der Kolk; Madieke I Liem; M Eline Kooi; Jeroen Hendrikse; Paul J Nederkoorn; Peter J Koudstaal; Aad van der Lugt; Daniel Bos Journal: Stroke Date: 2022-01-05 Impact factor: 7.914
Authors: Maximillian A Rogers; Samantha K Atkins; Kang H Zheng; Sasha A Singh; Sarvesh Chelvanambi; Tan H Pham; Shiori Kuraoka; Erik S G Stroes; Masanori Aikawa; Elena Aikawa Journal: Front Cardiovasc Med Date: 2022-01-28